Stay Updated with the Latest Pasinex Resources Limited PSE.CN News in Real Time
Find PSE.CN news now at Meyka AI. Stay informed with the latest Pasinex Resources Limited stocks updates, including price news, market analysis, and expert insights.
Coles Shares Fall 3.1% After Alcohol Pricing Glitch Crashes Website
Coles website crashes after viral Reddit post reveals 80% alcohol discount. Shares fall 3.1% to A$22.76. FY26 earnings due August 25. Meyka rates COL.AX a B-.
Massive Storm System Drenches Australia; Flooding Hits Victoria, NSW on August 24
A major low-pressure system is bringing heavy rain and storms across southeast Australia through Tuesday. Victoria and NSW face flooding risks as catchments remain saturated from recent rainfall.
Cardano Jumps 13.8% to $0.2266 as RSI Hits Overbought 69.5
ADAUSD surged 13.8% to $0.2266 in 24 hours with RSI at 69.5 and volume 63% above average, signaling strong short-term momentum.
Sui USD Surges 15.9% to $0.8508 as RSI Hits 66.9 on Strong Momentum
Sui USD jumped 15.9% to $0.8508 in 24 hours with volume 2.3x average. RSI at 66.9 and ADX at 29.95 signal strong upward momentum.
Dogecoin Jumps 16.1% to $0.0934 as RSI Signals Extreme Overbought
DOGEUSD surged 16.1% to $0.0934 in 24 hours with RSI at 75.78 and volume 2.1x average, signaling an overheated rally.
Fifth Third Backs Payload’s $500M Monthly Payments Platform on August 23
Fifth Third Bank invests in Payload, an embedded payments platform processing $500M monthly. The deal marks Payload’s first outside capital since 2019 and expands payment options across industries.
Solana Climbs 8.5% to $95.08 as RSI Hits Extreme Overbought 78.7
Solana USD surged 8.5% to $95.08 in 24 hours with RSI at 78.7, signaling overbought conditions and potential pullback risk.
Take-Two Subpoenas Microsoft, Discord Over GTA 6 Leaks; TTWO Slides 0.2%
Take-Two subpoenas Microsoft and Discord to identify GTA 6 leakers. Nine gameplay videos released by CyberLeek group; game launches November 19. TTWO stock down 0.2%.
Moderna and Merck’s Melanoma Vaccine Jumps Stocks on Phase 3 Win
Moderna and Merck’s personalized mRNA cancer vaccine succeeded in Phase 3 melanoma trials, reducing disease recurrence. MRNA jumped 8.9% and MRK rose 2.4% on the announcement.